Acute Respiratory Distress Syndrome

Study Finds New Cell Therapy Promising For ARDS Patients

The iNKT cell therapy helps replenish T cells and triggers an anti-inflammatory cytokine response. This may boost antiviral immunity, aiding patients in battling infections while also lessening severe lung inflammation.